Interrogating open issues in cancer precision medicine with patient-derived xenografts-Reference-Cited by-同舟云学术

Interrogating open issues in cancer precision medicine with patient-derived xenografts

Published:2017-01-20 Issue:4 Volume:17 Page:254-268
ISSN:1474-175X
Container-title:Nature Reviews Cancer
language:en
Short-container-title:Nat Rev Cancer

Author:

Byrne Annette T.,Alférez Denis G.,Amant Frédéric,Annibali Daniela,Arribas Joaquín,Biankin Andrew V.,Bruna Alejandra,Budinská Eva,Caldas Carlos,Chang David K.,Clarke Robert B.,Clevers Hans,Coukos George,Dangles-Marie Virginie,Eckhardt S. Gail,Gonzalez-Suarez Eva,Hermans Els,Hidalgo Manuel,Jarzabek Monika A.,de Jong Steven,Jonkers Jos,Kemper Kristel,Lanfrancone Luisa,Mælandsmo Gunhild Mari,Marangoni Elisabetta,Marine Jean-Christophe,Medico Enzo,Norum Jens Henrik,Palmer Héctor G.,Peeper Daniel S.,Pelicci Pier Giuseppe,Piris-Gimenez Alejandro,Roman-Roman Sergio,Rueda Oscar M.,Seoane Joan,Serra Violeta,Soucek Laura,Vanhecke Dominique,Villanueva Alberto,Vinolo Emilie,Bertotti Andrea,Trusolino Livio

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

http://www.nature.com/articles/nrc.2016.140.pdf

Reference179 articles.

1. de Bono, J. S. & Ashworth, A. Translating cancer research into targeted therapeutics. Nature 467, 543–549 (2010).

2. Daniel, V. C. et al. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res. 69, 3364–3373 (2009).

3. Arrowsmith, J. Trial watch: phase II failures: 2008–2010. Nat. Rev. Drug Discov. 10, 328–329 (2011).

4. Arrowsmith, J. & Miller, P. Trial watch: phase II and phase III attrition rates 2011–2012. Nat. Rev. Drug Discov. 12, 569 (2013).

5. Paul, S. M. et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat. Rev. Drug Discov. 9, 203–214 (2010).

Cited by 546 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging preclinical models of metastatic breast cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Extracellular matrix regulation of cell spheroid invasion in a 3D bioprinted solid tumor-on-a-chip;Acta Biomaterialia;2024-09

3. Repurposed AT9283 triggers anti-tumoral effects by targeting MKK3 oncogenic functions in Colorectal Cancer;Journal of Experimental & Clinical Cancer Research;2024-08-20

4. Evaluation of Combined Chemotherapy and Genomic-Driven Targeted Therapy in Patient-Derived Xenografts Identifies New Therapeutic Approaches in Squamous Non-Small-Cell Lung Cancer Patients;Cancers;2024-08-07

5. Gastrointestinal Cancer Patient Derived Organoids at the Frontier of Personalized Medicine and Drug Screening;Cells;2024-08-06